Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail)

v3.23.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Detail) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:      
Research and development tax credits $ 10,526,768 $ 9,475,588  
Net operating loss carryovers 76,477,629 67,785,680  
Property and equipment 162,698 189,271  
Research and development costs 9,829,326 10,923,959  
Start-up and organizational costs 9,275 462  
Stock-based compensation 283,285 4,659,555  
Operating lease liability 551,284 187,132  
Other accruals 464,948 670,065  
Total gross deferred tax assets 98,305,213 93,891,712  
Less: valuation allowance (97,756,771) (93,718,497) $ (82,929,675)
Total deferred tax assets 548,442 173,215  
Deferred tax liabilities:      
Operating lease right-of-use asset (548,442) (173,215)  
Total deferred tax liabilities (548,442) (173,215)  
Total deferred taxes, net $ 0 $ 0